Proposed Changes to Hospital Payment Structures by CMS in FY 2027

The Centers for Medicare & Medicaid Services (CMS) has unveiled a proposal to increase hospital operating rates by 2.4 percent in its Fiscal Year 2027 Inpatient Prospective Payment System (IPPS) rule. While this may appear as a simple rate adjustment, the broader implications for hospitals involve critical changes in payment structures and policies, affecting their financial and operational health significantly.

This proposal enforces tighter payment protocols and evolving Diagnosis-Related Group (DRG) logic, with stricter evidence requirements for new technology implementation. These changes pose challenges for hospitals managing complex care models and cutting-edge medical technologies. Stakeholders involved in revenue cycle management and financial strategy should submit comments by the June 9 deadline to influence the final rule effectively.

Notably, the CMS initiative expands policies on supplemental payments, improves payment designs based on episodes of care, and revises standards for graduate medical education. This shift reflects a strategic move away from general rate increases towards more nuanced, evidence-based payment approaches that hospitals must recognize as indicative of future trends.

A significant proposal is the elimination of specific New Technology Add-on Payment (NTAP) pathways, including those associated with FDA Breakthrough Device designation from Fiscal Year 2028. Though NTAP remains, the proposal raises evidence criteria for early funding approval for new technologies. Hospitals must incorporate NTAP considerations into their operational and financial planning, beyond just manufacturer concerns.

CMS also proposes changes to DRG assignment and grouping logic, affecting case mix forecasts and clinical documentation management. These adjustments could shift reimbursement outcomes at a procedural level, prompting revenue cycle teams to anticipate and adapt to these changes.

Additionally, CMS introduces a new nationwide mandatory payment model, CJR-X, starting in October 2027, focusing on episodes of care. This model highlights retrospective settlement and coordinated care beyond initial hospital admissions, impacting cash flow and reserve strategies.

To address these changes, hospitals should evaluate vulnerable DRGs, technologies, and service lines and develop comprehensive comments highlighting specific financial exposures. Emphasizing alternative strategies or transitional models will ensure evidence thresholds do not hinder access to essential technologies. By intensifying data simulations, documentation workflows, and reimbursement processes, healthcare organizations can align more closely with CMS's evidence-based policies, enhancing financial resilience and operational capabilities.